Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3973578
Max Phase: Preclinical
Molecular Formula: C19H22N2OS
Molecular Weight: 326.47
Molecule Type: Small molecule
Associated Items:
ID: ALA3973578
Max Phase: Preclinical
Molecular Formula: C19H22N2OS
Molecular Weight: 326.47
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1cnc(SCC(=O)N2CCCc3cccc(C)c32)cc1C
Standard InChI: InChI=1S/C19H22N2OS/c1-13-6-4-7-16-8-5-9-21(19(13)16)18(22)12-23-17-10-14(2)15(3)11-20-17/h4,6-7,10-11H,5,8-9,12H2,1-3H3
Standard InChI Key: KTHJQHSQBKPZKR-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 326.47 | Molecular Weight (Monoisotopic): 326.1453 | AlogP: 4.08 | #Rotatable Bonds: 3 |
Polar Surface Area: 33.20 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 4.51 | CX LogP: 4.47 | CX LogD: 4.47 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.80 | Np Likeness Score: -1.71 |
1. (2015) Compounds of modulating TRPV3 function, |
Source(1):